Skip to content
XSNX 0.08 -0.04 -33.56%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
XSNX 0.08 -0.04 -33.56%
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Menu
Home
Our Mission
Science & Tech
StemVax
Team
Investors
News
Publications
Press Releases
SEC Filings
Presentations
Contact
Day:
July 19, 2022
NovAccess Global Announces Filing of Orphan Drug Application for TLR-AD1